Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)

PURPOSE: In men with localized prostate cancer, dose-escalated conformal radiotherapy (CFRT) improves efficacy outcomes at the cost of increased toxicity. We present a detailed analysis to provide further information about the incidence and prevalence of late gastrointestinal side effects. METHODS A...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Syndikus, Isabel, Morgan, Rachel C., Sydes, Matthew R., Graham, John D., Dearnaley, David P.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Science Inc 2010
Matèries:
Clinical Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2937212/
https://ncbi.nlm.nih.gov/pubmed/19836155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2009.05.052
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars